• Thumbnail for Trastuzumab
    Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically...
    69 KB (6,103 words) - 11:49, 17 November 2024
  • Thumbnail for Trastuzumab deruxtecan
    Trastuzumab deruxtecan, sold under the brand name Enhertu, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin)...
    25 KB (2,086 words) - 02:24, 16 July 2024
  • Thumbnail for Trastuzumab emtansine
    Trastuzumab emtansine, sold under the brand name Kadcyla, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin)...
    29 KB (2,696 words) - 14:16, 27 July 2024
  • Pertuzumab/trastuzumab/hyaluronidase, sold under the brand name Phesgo, is a fixed-dose combination medication to treat adults with HER2-positive breast...
    12 KB (966 words) - 04:46, 15 July 2024
  • Thumbnail for Cancer immunotherapy
    system. Examples of such antibodies include rituximab (targeting CD-20), trastuzumab (targeting HER-2), and cetuximab (targeting EGFR). Passive antibody therapies...
    92 KB (12,517 words) - 05:38, 1 October 2024
  • Trastuzumab/hyaluronidase, sold under the brand name Herceptin SC among others, is a fixed-dose combination medication for the treatment of HER2-overexpressing...
    11 KB (703 words) - 18:13, 27 March 2024
  • Thumbnail for HER2
    antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is...
    43 KB (4,651 words) - 13:41, 27 July 2024
  • Thumbnail for Pertuzumab
    brand name Perjeta, is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer;...
    24 KB (2,276 words) - 04:42, 1 October 2024
  • Thumbnail for Tucatinib
    2021. Tucatinib is a kinase inhibitor indicated in combination with trastuzumab and capecitabine for the treatment of adults with advanced unresectable...
    21 KB (1,685 words) - 05:17, 16 July 2024
  • Thumbnail for Antibody–drug conjugate
    authorization from the European Medicines Agency in October 2012. Trastuzumab emtansine (ado-trastuzumab emtansine or T-DM1, trade name: Kadcyla, marketed by Genentech...
    41 KB (4,305 words) - 11:56, 24 August 2024
  • Thumbnail for Succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate
    example, a targeted anticancer agent – trastuzumab emtansine (antibody-drug conjugate containing an antibody trastuzumab chemically linked to a highly potent...
    2 KB (97 words) - 22:42, 6 February 2024
  • Isatuximab L01FD01 Trastuzumab L01FD02 Pertuzumab L01FD03 Trastuzumab emtansine L01FD04 Trastuzumab deruxtecan L01FD05 Trastuzumab duocarmazine L01FD06...
    12 KB (877 words) - 15:36, 25 January 2024
  • Thumbnail for Exatecan
    of camptothecin with antineoplastic activity. A derivative is used in Trastuzumab deruxtecan. Abou-Alfa, GK; Letourneau, R; Harker, G; Modiano, M; Hurwitz...
    3 KB (98 words) - 05:18, 1 January 2024
  • aspart, insulin glargine, pegfilgrastim, rituximab, teriparatide, and trastuzumab. A research article about "Maximizing the benefits of using biosimilars...
    97 KB (6,512 words) - 06:28, 8 October 2024
  • Kadcyla (ado-trastuzumab emtansine): The first Genentech antibody-drug conjugate (ADC) to receive FDA approval. It consists of trastuzumab (Herceptin)...
    32 KB (2,865 words) - 04:21, 4 October 2024
  • Thumbnail for Uterine serous carcinoma
    antibody trastuzumab (Herceptin) is currently being tested as a therapy for this subset of uterine serous carcinomas. The antibody trastuzumab (Herceptin)...
    10 KB (1,197 words) - 17:13, 13 June 2024
  • Thumbnail for Mertansine
    create an antibody-drug conjugate (ADC). ADCs with this design include trastuzumab emtansine, lorvotuzumab mertansine, and cantuzumab mertansine. Some are...
    6 KB (471 words) - 09:43, 12 February 2024
  • Thumbnail for Breast cancer
    HER2-targeted antibody trastuzumab to chemotherapy reduces the chance of cancer recurrence and death by at least a third. Trastuzumab is given weekly or every...
    134 KB (15,172 words) - 09:52, 13 November 2024
  • Thumbnail for Oncology
    antibody treatments, notably for lymphoma (Rituximab) and breast cancer (Trastuzumab). Vaccines and other immunotherapies are the subject of intensive research...
    24 KB (2,589 words) - 20:46, 24 September 2024
  • Thumbnail for Hyaluronidase
    (Rituxan Hycela), trastuzumab/hyaluronidase-oysk (Herceptin Hylecta), daratumumab/hyaluronidase-fihj (Darzalex Faspro), and pertuzumab/trastuzumab/hyaluronidase–zzxf...
    34 KB (3,092 words) - 05:38, 14 September 2024
  • Thumbnail for Doxorubicin
    other cardiotoxic chemotherapy drugs, such as trastuzumab. There is an FDA black box warning that trastuzumab cannot be used in concurrent combination with...
    49 KB (4,504 words) - 07:10, 21 November 2024
  • Cancer Institute.⁣⁣ He is best known for his research on treatments with trastuzumab in HER2-positive breast cancers. Pivot was born on April 20, 1967, in...
    11 KB (1,127 words) - 17:13, 3 December 2023
  • Thumbnail for Natural killer cell
    NK cell effector functions during NK cell anti-tumor immunotherapy. Trastuzumab is a monoclonal anti-HER2 antibody that is used as a treatment of the...
    75 KB (9,227 words) - 23:32, 16 October 2024
  • (INN) trapencaine (INN) trapidil (INN) Trasicor Trastucip trastuzumab emtansine (INN) trastuzumab (INN) Trasylol Travamulsion Travase Travasol Travatan travoprost...
    12 KB (563 words) - 00:00, 1 October 2024
  • Thumbnail for Antibody-dependent cellular cytotoxicity
    proteins to activate the NK cell. The effects against solid tumors of trastuzumab and rituximab monoclonal antibodies have been shown in experiments with...
    13 KB (1,661 words) - 22:18, 9 December 2023
  • monoclonal antibody (mAb) approved by the EMA. Herzuma is a biosimilar trastuzumab approved by the MFDS for treatment of early and advanced (metastatic)...
    12 KB (809 words) - 09:31, 17 November 2024
  • Thumbnail for Roche
    lymphocytic leukaemia. Hemlibra (emicizumab), for haemophilia A. Herceptin (trastuzumab), for HER-2 positive breast cancer. Hivid (zalcitabine), for HIV-1 infection...
    57 KB (5,195 words) - 10:21, 4 November 2024
  • TCH is a chemotherapy regimen consisting of Taxotere (docetaxel), carboplatin and Herceptin (trastuzumab), which is used to treat breast cancer. v t e...
    623 bytes (23 words) - 14:38, 23 October 2018
  • Thumbnail for Mechanism of action
    likely to respond to treatment. Because the breast cancer medication trastuzumab is known to target protein HER2, for example, tumors can be screened...
    17 KB (1,857 words) - 06:00, 19 August 2024
  • Thumbnail for Daiichi Sankyo
    Sankyo.” This list is not comprehensive. Oncology Enhertu (trastuzumab deruxtecan, fam-trastuzumab deruxtecan-nxki in the United States only) Ezharmia (valemetostat)...
    28 KB (2,326 words) - 02:38, 5 September 2024